These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 21943887)

  • 1. Donepezil dosing strategies: pharmacokinetic considerations.
    Gomolin IH; Smith C; Jeitner TM
    J Am Med Dir Assoc; 2011 Oct; 12(8):606-608. PubMed ID: 21943887
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A fixed-dose combination of memantine extended-release and donepezil in the treatment of moderate-to-severe Alzheimer's disease.
    Deardorff WJ; Grossberg GT
    Drug Des Devel Ther; 2016; 10():3267-3279. PubMed ID: 27757016
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.
    Homma A; Atarashi H; Kubota N; Nakai K; Takase T
    J Alzheimers Dis; 2016 Mar; 52(1):345-57. PubMed ID: 26967222
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Significant dose differences in donepezil purchased from the United States and Canada.
    Wang CZ; Du GJ; Zhen Z; Calway T; Yuan CS
    Ann Intern Med; 2011 Aug; 155(4):279-80. PubMed ID: 21844564
    [No Abstract]   [Full Text] [Related]  

  • 6. Concurrent administration of donepezil HCl and risperidone in patients with schizophrenia: assessment of pharmacokinetic changes and safety following multiple oral doses.
    Reyes JF; Preskorn SH; Khan A; Kumar D; Cullen EI; Perdomo CA; Pratt RD
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):50-7. PubMed ID: 15496223
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic dosage assessment based on population pharmacokinetics of a novel single-dose transdermal donepezil patch in healthy volunteers.
    Choi HY; Kim YH; Hong D; Kim SS; Bae KS; Lim HS
    Eur J Clin Pharmacol; 2015 Aug; 71(8):967-77. PubMed ID: 26014587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of pharmacokinetic or pharmacodynamic interaction between memantine and donepezil.
    Periclou AP; Ventura D; Sherman T; Rao N; Abramowitz WT
    Ann Pharmacother; 2004 Sep; 38(9):1389-94. PubMed ID: 15266045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of chongmyungtang, a traditional Korean polyherbal formula, on the Pharmacokinetic profiles of donepezil in rats.
    Baek KM; Kwon OD; Park SJ; Song CH; Ku SK
    Pak J Pharm Sci; 2017 Jan; 30(1):103-97. PubMed ID: 28603119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Concurrent administration of donepezil HCl and sertraline HCl in healthy volunteers: assessment of pharmacokinetic changes and safety following single and multiple oral doses.
    Nagy CF; Kumar D; Perdomo CA; Wason S; Cullen EI; Pratt RD
    Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):25-33. PubMed ID: 15496220
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of the pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy young and elderly subjects.
    Ohnishi A; Mihara M; Kamakura H; Tomono Y; Hasegawa J; Yamazaki K; Morishita N; Tanaka T
    J Clin Pharmacol; 1993 Nov; 33(11):1086-91. PubMed ID: 8300891
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction study of aspirin or clopidogrel on pharmacokinetics of donepezil hydrochloride in rats by HPLC-fluorescence detection.
    Wada M; Nishiwaki J; Yamane T; Ohwaki Y; Aboul-Enein HY; Nakashima K
    Biomed Chromatogr; 2007 Jun; 21(6):616-20. PubMed ID: 17340563
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concurrent administration of donepezil HCl and theophylline: assessment of pharmacokinetic changes following multiple-dose administration in healthy volunteers.
    Tiseo PJ; Foley K; Friedhoff LT
    Br J Clin Pharmacol; 1998 Nov; 46 Suppl 1(Suppl 1):35-9. PubMed ID: 9839764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacodynamics of cholinesterase inhibitors suggests add-on therapy with a low-dose carbamylating inhibitor in patients on long-term treatment with rapidly reversible inhibitors.
    Darreh-Shori T; Hosseini SM; Nordberg A
    J Alzheimers Dis; 2014; 39(2):423-40. PubMed ID: 24217282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Local Drug-Drug Interaction of Donepezil with Cilostazol at Breast Cancer Resistance Protein (ABCG2) Increases Drug Accumulation in Heart.
    Takeuchi R; Shinozaki K; Nakanishi T; Tamai I
    Drug Metab Dispos; 2016 Jan; 44(1):68-74. PubMed ID: 26467765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Donepezil use in Alzheimer disease.
    Barner EL; Gray SL
    Ann Pharmacother; 1998 Jan; 32(1):70-7. PubMed ID: 9475825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Donepezil across the spectrum of Alzheimer's disease: dose optimization and clinical relevance.
    Lee JH; Jeong SK; Kim BC; Park KW; Dash A
    Acta Neurol Scand; 2015 May; 131(5):259-67. PubMed ID: 25690270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donepezil (Aricept) for treatment of Alzheimer's disease and other dementing conditions.
    Geldmacher DS
    Expert Rev Neurother; 2004 Jan; 4(1):5-16. PubMed ID: 15853610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of increasing donepezil in mild to moderate Alzheimer's disease patients who show a diminished response to 5 mg donepezil: a preliminary study.
    Yatabe Y; Hashimoto M; Kaneda K; Honda K; Ogawa Y; Yuuki S; Ikeda M
    Psychogeriatrics; 2013 Jun; 13(2):88-93. PubMed ID: 23909965
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of E2020, a new compound for Alzheimer's disease, in healthy male volunteers.
    Mihara M; Ohnishi A; Tomono Y; Hasegawa J; Shimamura Y; Yamazaki K; Morishita N
    Int J Clin Pharmacol Ther Toxicol; 1993 May; 31(5):223-9. PubMed ID: 8314652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.